Verano Holdings (VRNO) Cash from Financing Activities (2021 - 2026)

Verano Holdings' (VRNO) quarterly Cash from Financing Activities came in at -$12.4 million in Q1 2026, down 1994.42% year-on-year from $653393.9 in Q1 2025, and down 230.61% on a QoQ basis from -$3.7 million in Q4 2025.

Verano Holdings (VRNO) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cash from Financing Activities data on file, last reported at -$12.4 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 1994.42% year-over-year to -$12.4 million in Q1 2026; TTM through Mar 2026 was -$37.1 million, a 42.2% increase from a year earlier, with the FY2025 full-year figure at -$25.3 million, up 61.59% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at -$12.4 million, down from -$3.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for VRNO reached as high as $92.8 million in Q1 2022 and fell as low as -$53.2 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged $586705.9 across 5 years, with a median of -$2.3 million in 2024.
  • Across the five-year window, Cash from Financing Activities soared 975.57% in 2023 and plunged 1994.42% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $2.1 million in 2022, then surged by 975.57% to $22.3 million in 2023, then sank by 137.15% to -$8.3 million in 2024, then surged by 54.84% to -$3.7 million in 2025, then sank by 230.61% to -$12.4 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$12.4 million in Q1 2026, -$3.7 million in Q4 2025, and -$4.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -12.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.38 Mn
Mar 31, 2026 -12.38 Mn
Dec 31, 2025 -3.74 Mn
Dec 31, 2025 -3.74 Mn
Sep 30, 2025 -4.85 Mn
Sep 30, 2025 -4.85 Mn
Jun 30, 2025 -16.14 Mn
Jun 30, 2025 -16.14 Mn
Mar 31, 2025 -591,000.00
Mar 31, 2025 -591,000.00
Dec 31, 2024 -8.29 Mn
Dec 31, 2024 -8.29 Mn
Sep 30, 2024 -2.17 Mn
Sep 30, 2024 -2.17 Mn
Jun 30, 2024 -53.15 Mn
Jun 30, 2024 -53.15 Mn
Mar 31, 2024 -2.32 Mn
Mar 31, 2024 -2.32 Mn
Dec 31, 2023 22.32 Mn
Dec 31, 2023 22.32 Mn